Old Web
English
Sign In
Acemap
>
Paper
>
Antibodies in Phase III Studies for Immunological Disorders
Antibodies in Phase III Studies for Immunological Disorders
2014
Penelope Ward
Mark Bodmer
Keywords:
Epratuzumab
Gevokizumab
Sarilumab
Gantenerumab
Sirukumab
Itolizumab
Immunology
Lebrikizumab
Tabalumab
Biology
Bapineuzumab
Autoimmunity
Ixekizumab
Antibody
Solanezumab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
256
References
0
Citations
NaN
KQI
[]